Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Michael Bröker
Observed names:
Bröker, Michael,
M BROKER,
M Bröker,
M. Broker,
M. Bröker,
MICHAEL BRÖKER
show all 6
Observed institutions:
Novartis (Switzerland),
University Medical Center Freiburg,
Novartis (Germany),
Behringwerke (Germany),
Novartis (United States),
GlaxoSmithKline (Germany),
Chiron (Norway)
show all 7
OpenAlex ID:
A5113714302
Biochemical and biological characteristics of cross-reacting material 197 (CRM197), a non-toxic mutant of diphtheria toxin: Use as a conjugation protein in vaccines and other potential clinical applications
2011
·
Michael Bröker
, Paolo Costantino
, et al.
·
Biologicals
·
131
Tick-Borne Encephalitis in Mainland China
2008
·
Zhi Lu
, Michael Bröker
, et al.
·
Vector-Borne and Zoonotic Diseases
·
111
Polysaccharide conjugate vaccine protein carriers as a “neglected valency” – Potential and limitations
2017
·
Michael Bröker
, Francesco Berti
, et al.
·
Vaccine
·
95
PDF
Chemistry of a new investigational quadrivalent meningococcal conjugate vaccine that is immunogenic at all ages
2009
·
Michael Bröker
, Peter M. Dull
, et al.
·
Vaccine
·
86
Serum bactericidal antibody assays – The role of complement in infection and immunity
2015
·
E.D.G. McIntosh
, M. Bröker
, et al.
·
Vaccine
·
85
The Spatial Distribution of Dermacentor Ticks (Ixodidae) in Germany—Evidence of a Continuing Spread of Dermacentor reticulatus
2020
·
Marco Drehmann
, Andrea Springer
, et al.
·
Frontiers in Veterinary Science
·
82
PDF
Protection of immunocompromised mice against lethal infection with Pseudomonas aeruginosa by active or passive immunization with recombinant P. aeruginosa outer membrane protein F and outer membrane protein I fusion proteins
1995
·
B U von Specht
, B Knapp
, et al.
·
Infection and Immunity
·
77
Safety of MDCK Cell Culture-Based Influenza Vaccines
2011
·
Jens-Peter Gregersen
, Heinz-Josef Schmitt
, et al.
·
Future Microbiology
·
72
Meningococcal serogroup Y disease in Europe: Continuation of high importance in some European regions in 2013
2015
·
Michael Bröker
, Stéphane Emonet
, et al.
·
Human Vaccines & Immunotherapeutics
·
63
PDF
Expression of human antithrombin III in Saccharomyces cerevisiae and Schizosaccharomyces pombe
1987
·
Michael Bröker
, Hermann Ragg
, et al.
·
Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression
·
63
Invasive meningococcal disease and travel
2010
·
Ziad A. Memish
, Anette Goubeaud
, et al.
·
Journal of Infection and Public Health
·
62
PDF
After a tick bite in a tick-borne encephalitis virus endemic area: Current positions about post-exposure treatment
2007
·
Michael Bröker
, Herwig Kollaritsch
·
Vaccine
·
55
Factors contributing to the immunogenicity of meningococcal conjugate vaccines
2016
·
Michael Bröker
, Francesco Berti
, et al.
·
Human Vaccines & Immunotherapeutics
·
52
Tick-borne encephalitis vaccines: past and present
2005
·
Olaf Zent
, Michael Bröker
·
Expert Review of Vaccines
·
52
Simple determination of polysaccharide specific antibodies by means of chemically modified ELISA plates
1996
·
S. Zielen
, M. Bröker
, et al.
·
Journal of Immunological Methods
·
51
Prokaryotic Expression of Immunogenic Polypeptides of the Large Phosphoprotein (pp150) of Human Cytomegalovirus
1988
·
B.-C. Scholl
, J. von Hintzenstern
, et al.
·
Journal of General Virology
·
48
Meningococcal serogroup Y emergence in Europe
2012
·
Michael Bröker
, Susanne Jacobsson
, et al.
·
Human Vaccines & Immunotherapeutics
·
46
PDF
Are tick-borne encephalitis vaccines interchangeable?
2006
·
Michael Bröker
, Ines Schöndorf
·
Expert Review of Vaccines
·
46
Winter activity of questing ticks (Ixodes ricinus and Dermacentor reticulatus) in Germany − Evidence from quasi-natural tick plots, field studies and a tick submission study
2023
·
Julia Probst
, Andrea Springer
, et al.
·
Ticks and Tick-borne Diseases
·
43
Potential protective immunogenicity of tetanus toxoid, diphtheria toxoid and Cross Reacting Material 197 (CRM197) when used as carrier proteins in glycoconjugates
2015
·
Michael Bröker
·
Human Vaccines & Immunotherapeutics
·
40
PDF
New foci of tick-borne encephalitis virus in Europe: consequences for travellers from abroad
2003
·
Michael Bröker
, Dieter Gniel
·
Travel Medicine and Infectious Disease
·
40
Vectors for regulated high-level expression of proteins fused to truncated forms of Escherichia coli β-galactosidase
1986
·
Michael Bröker
·
Gene Analysis Techniques
·
39
Morphological anomalies in Ixodes ricinus and Ixodes inopinatus collected from tick-borne encephalitis natural foci in Central Europe
2017
·
Lidia Chitimia-Dobler
, Malena Bestehorn
, et al.
·
Experimental and Applied Acarology
·
38
Meningococcal serogroup Y emergence in Europe
2014
·
Michael Bröker
, Suzana Bukovski
, et al.
·
Human Vaccines & Immunotherapeutics
·
31
PDF
pSEM vectors: high level expression of antigenic determinants and protein domains.
1990
·
S Knapp
, M Bröker
, et al.
·
PubMed
·
28
Show more works
View as search
Works count:
95
Citation count:
2,068
H-index:
26
I10-index:
45
Year
Topic
Type
